Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Clinical trial NCT04142931 · UNKNOWN

Trial details

NCT number: NCT04142931
Sponsor: Dr. Ronnie Shapira
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Stage IV Non-small Cell Lung Cancer Stage IV Melanoma Triple Negative Breast Cancer Renal Cell Carcinoma Stage IV

Start date: 2020-02-24
Primary completion: 2021-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.